Latest Breaking News On - Prnewswire faron pharmaceuticals oy - Page 1 : comparemela.com

Faron Pharmaceuticals Oy   Faron Announces New Biomarker Data from Phase I/II BEXMAB Study at EHA2023 Hybrid Congress Bexmarilimab mode of action in AML/MDS supported with durable Clever-1. | June 9, 2023

United statesJuha karttunenSandy jamiesonJo turnerChristopher goldenLindsey nevilleJenniferc smith parkerJulia balanovaDavid daleyHead of communicationsPrnewswire faron pharmaceuticals oyCongress onFaron pharmaceuticals oyPeel huntCairn financial advisersFaron pharmaceuticals